These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24245426)

  • 1. [Doping affects the entire society].
    Sundberg CJ
    Lakartidningen; 2013 Sep 25-Oct 8; 110(39-40):1727. PubMed ID: 24245426
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethical considerations in anti-doping analysis.
    Murray TH
    Bioanalysis; 2012 Jul; 4(13):1537-9. PubMed ID: 22831469
    [No Abstract]   [Full Text] [Related]  

  • 3. Current limitations in analytical strategies.
    Howman D
    Bioanalysis; 2012 Jul; 4(13):1535-6. PubMed ID: 22831468
    [No Abstract]   [Full Text] [Related]  

  • 4. Half a century of challenges.
    Ljungqvist A
    Bioanalysis; 2012 Jul; 4(13):1531-3. PubMed ID: 22831467
    [No Abstract]   [Full Text] [Related]  

  • 5. Should athletes be allowed to use performance enhancing drugs?
    Savulescu J; Creaney L; Vondy A
    BMJ; 2013 Oct; 347():f6150. PubMed ID: 24149520
    [No Abstract]   [Full Text] [Related]  

  • 6. Keeping it Clean.
    Mahaffey BL
    Mo Med; 2015; 112(3):171. PubMed ID: 26168583
    [No Abstract]   [Full Text] [Related]  

  • 7. Doping in East Germany: drugs as a geopolitical tool.
    Prescrire Int; 2016 Oct; 25(175):251. PubMed ID: 30645836
    [No Abstract]   [Full Text] [Related]  

  • 8. [Steroids are a growing problem at gyms].
    Rane A; Rosén T; Skårberg K; Heine L; Ljungdahl S
    Lakartidningen; 2013 Sep 25-Oct 8; 110(39-40):1741-6. PubMed ID: 24245430
    [No Abstract]   [Full Text] [Related]  

  • 9. Can we trust doping tests?
    Waaler HT; Siem H; Aalen OO
    Tidsskr Nor Laegeforen; 2011 Sep; 131(18):1760-1. PubMed ID: 21946591
    [No Abstract]   [Full Text] [Related]  

  • 10. Concerning the viewpoint; "An anti-doping sampling strategy utilizing the sewerage systems of sport villages".
    Harman C; Reid M; Thomas KV
    Environ Sci Technol; 2011 May; 45(10):4191; author reply 4192. PubMed ID: 21500825
    [No Abstract]   [Full Text] [Related]  

  • 11. [Doping is serious cheating--and the destiny issue of sports. The modern anti-doping work began in 1961].
    Ljungqvist A
    Lakartidningen; 2012 Jul 18-Aug 8; 109(29-31):1337-8. PubMed ID: 22913112
    [No Abstract]   [Full Text] [Related]  

  • 12. Avoiding contractual liability to baseball players who have used performance enhancing drugs: can we knock it out of the park?
    Gottlieb B
    Albany Law Rev; 2013-2014; 77(2):615-37. PubMed ID: 24851323
    [No Abstract]   [Full Text] [Related]  

  • 13. Performance-enhancing substance misuse in sport: risk factors and considerations for success and failure in intervention programs.
    Bahrke MS
    Subst Use Misuse; 2012; 47(13-14):1505-16. PubMed ID: 23186455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Every physician must be familiar with the doping list. Doping classified substances should be avoided for athletes--sometimes dispensation is necessary].
    Eriksson BO
    Lakartidningen; 2012 Jul 18-Aug 8; 109(29-31):1345-6. PubMed ID: 22913115
    [No Abstract]   [Full Text] [Related]  

  • 15. Performance enhancing agents and the heart.
    Taylor J
    Eur Heart J; 2014 Nov; 35(44):3080. PubMed ID: 25568910
    [No Abstract]   [Full Text] [Related]  

  • 16. An anti-doping sampling strategy utilizing the sewerage systems of sport villages.
    Katsoyiannis A; Jones KC
    Environ Sci Technol; 2011 Jan; 45(2):362-3. PubMed ID: 21142144
    [No Abstract]   [Full Text] [Related]  

  • 17. A false start in the race against doping in sport: concerns with cycling's biological passport.
    Hailey N
    Duke Law J; 2011 Nov; 61(2):393-432. PubMed ID: 22069854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Anti Doping Hot-Line answers questions, educate, network, research...].
    Böttiger Y; Gårevik N; Sjöqvist F
    Lakartidningen; 2013 Sep 25-Oct 8; 110(39-40):1728-30. PubMed ID: 24245427
    [No Abstract]   [Full Text] [Related]  

  • 19. The analytical challenges of anti-doping analysis.
    Harrison CR
    Anal Bioanal Chem; 2013 Dec; 405(30):9615-6. PubMed ID: 24043378
    [No Abstract]   [Full Text] [Related]  

  • 20. Stan Reents on Mike Bahrke's "Performance-enhancing substance misuse in sport: intervention programs". Testing for doping: pitfalls.
    Reents S
    Subst Use Misuse; 2012; 47(13-14):1521-2. PubMed ID: 23186458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.